Dermatitis herpetiformis secondary prevention

Revision as of 01:43, 8 January 2021 by AmberJavaid (talk | contribs)
Jump to navigation Jump to search

Dermatitis herpetiformis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatitis herpetiformis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatitis herpetiformis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatitis herpetiformis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dermatitis herpetiformis secondary prevention

CDC on Dermatitis herpetiformis secondary prevention

Dermatitis herpetiformis secondary prevention in the news

Blogs on Dermatitis herpetiformis secondary prevention

Directions to Hospitals Treating Dermatitis herpetiformis

Risk calculators and risk factors for Dermatitis herpetiformis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Secondary Prevention

Strict adherence to gluten free diet and dapsone, should improve the symptoms in few days. After tapering of dapsone, patient should be instructed to continue gluten free diet because it prevents the reappearance of symptoms and prevent the complications of celiac disease [1].

References

  1. Cardones AR, Hall RP 3rd. Management of dermatitis herpetiformis. Immunol Allergy Clin North Am. 2012 May;32(2):275-81, vi-vii. doi: 10.1016/j.iac.2012.04.007. Epub 2012 Apr 18. PMID: 22560140.

Template:WH Template:WS